SEC Form 4/A · accession 0001415889-18-000742
Niagen Bioscience, Inc. · NAGE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Robert N Fried
Officer — PRESIDENT, COO · Director
Period of report
May 15, 2018
Accepted (ET)
May 16, 2018 · 12:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001386570
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 15, 2018 | P | 10,000 | $3.63 | A | 926,574 | D | |
| Common StockF2 | holding | — | — | — | 12,744 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This Form 4 is being amended to correct the transaction code to reflect that the shares were purchased by the Reporting Person on the open market.
- F26,744 shares held by Jeremy Fried and 6,000 shares held by Benjamin Fried, who are both sons of Robert Fried.